Login / Signup

Immunology of COVID-19 and disease-modifying therapies: The good, the bad and the unknown.

Tobias ZrzavyIsabella WimmerPaulus Stefan RommerThomas Berger
Published in: European journal of neurology (2020)
Despite the knowledge gain over the last few months, current evidence remains limited, and, thus, further clinical vigilance and systematic documentation is essential.
Keyphrases
  • coronavirus disease
  • sars cov
  • healthcare
  • electronic health record
  • advance care planning
  • respiratory syndrome coronavirus